Latest broker research reports with buy, sell, hold recommendations along with forecast share price targets and upside.
Browse thousands of reports and search by company or the broker.
- This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report. (eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
RESEARCH REPORTS ALERTS
All Recent
Upside
Buy
Sell
Recent Upgrades
Recent Downgrades
IPO
Sector Updates
Most Recent
Top Upside
Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.
Robust product pipeline of promising niche products to fuel long term future growth, Strong Product Portfolio with significant brand market share in respective therapeutic segment, PANACEA is amongst the top 50 innovators in India with strong foundation of over two decades. Eyeing on Recent updates & highlights Amongst 6 WHO pre-qualified Suppliers of pentavalent vaccine US ANDAs - 3 approved; 3 pending for approval; 23 under development...